Plus ça change by Robertson, Miranda
This month, the two flagship biology journals of BioMed 
Central, Journal of Biology and BMC Biology, join forces 
under the title BMC Biology, as a journal whose aim is to 
maintain  and  develop  the  strengths  of  both.  We  have 
chosen  the  title  BMC  Biology  not  as  a  signal  of  the 
predominance of that journal over Journal of Biology, but 
to  affirm  the  connection  of  the  fused  publication  with 
BioMed Central, and its close relationship with its sibling 
journals of the BMC series (see [1]). But we like the genetic 
principle of codominance; and of course hybrid vigor.
That  said,  the  fused  publication  will  look  and  behave 
more like Journal of Biology than BMC Biology in most 
ways. We shall continue to publish the topical and authori­
tative review and comment that have regularly appeared in 
Journal  of  Biology,  which  will  also  bring  its  publication 
policy and speed of response to the fused journal (more on 
policy  below).  But  listing  on  the  Web  of  Science  and 
Journal Citation Record will be as BMC Biology.
In combining two journals, we are swimming against the 
tide of ever­proliferating new journals, a point remarked 
by  Gregory  Petsko  in  a  Comment  [2]  written  for  us  to 
mark  the  occasion  and  in  which,  with  the  verve  and 
effrontery with which regular readers of his column in our 
sister journal Genome Biology will be familiar, he deplores 
such  proliferation  –  inviting,  perhaps,  dissent.  But  we 
agree of course that this particular fusion is rational.
In the combined journal, what is new, and what is not?
What’s new
To launch the new BMC Biology, we are publishing the 
first  in  an  occasional  series  of  special  question­and­
answer  features,  in  which  we  invite  biologists  with  a 
strong personal view on a subject of topical interest or 
fundamental  importance  to  record  a  video  interview 
which is posted online with the edited text, and so can be 
viewed  or  read,  or  both,  according  to  preference.  Our 
first interviewee is Martin Raff, the founding Editor­in­
Chief of Journal of Biology and member of the Editorial 
Board of the fused journal. He speaks on autism [3], in 
which  he  developed  a  passionate  interest  when  his 
grandson was diagnosed at a year and a half as autistic, 
and tackles issues ranging from the promise of genomic 
and induced stem cell technologies to the reasons for the 
apparent increase in incidence.
The next Video Q&A, to be posted in May, will be from 
John Mattick, on the importance and roles of noncoding 
RNA ­ just as passionate, and ­ at least as concerns his 
perspective on biology ­ just as personal.
We also have a new emblematic image (Figure 1).
What’s not
BMC Biology and Journal of Biology between them have 
been committed to the publication of biological research 
papers  of  sufficient  interest  or  importance  to  justify 
drawing them to the attention of a broad general reader­
ship,  and  papers  selected  for  publication  in  the  fusion 
journal will reflect, by and large, the selection criteria of  © 2010 BioMed Central Ltd
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Figure 1. The BMC Biology image. The problem of representing 
all of biology is encapsulated in the image we have devised as 
an emblem for the fusion journal. Our protocellular lipid bilayer 
surrounding a circular representation of a rootless phylogenetic tree 
omits explicit reference to molecular and cellular structure and much 
else; and purists will find fault with the phylogeny. We must ask you 
all to settle for the Gestalt.
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both parents, so that the range of papers published will 
be greater than for either.
But  although  some  papers  are  undoubtedly  more 
worthy of general attention than others, biology, in the 
main,  has  become  so  specialized,  and  biologists  so 
focused, that there are few research papers that can be 
comfortably  read,  still  less  properly  appreciated,  by 
people  much  outside  their  immediate  field.  Journal  of 
Biology  has  addressed  this  paradox  of  the  so­called 
general journal by publishing short commentaries, which 
it has called minireviews, with two functions. For those 
papers  selected  for  publication  in  the  journal  for  their 
exceptional  interest  or  importance,  it  has  published  a 
commentary explaining the significance of the paper for 
nonspecialists.  Papers  making  a  significant  but  less 
striking contribution, including not only many published 
by BMC Biology, but also a selection of those published in 
other journals published by BioMed Central, have been 
the  stimulus  for  minireviews  giving  a  more  general 
perspective on the issues they reflect or address. This will 
continue in the new BMC Biology, except that the two 
functions  of  the  minireviews  will  be  explicit  in  two 
different names: those on papers of exceptional interest 
will be called ‘Focus’, and those with a broader remit will 
be called ‘Commentary’.
More of the same, with an experimental twist
Journal of Biology will also bring to the fusion its policy 
(already  shared  in  part  with  BMC  Biology)  of  taking 
advice from Editorial Board members on the suitability in 
principle of submitted papers for the journal before send­
ing them to referees, so that referees are asked to judge 
only  the  technical  soundness  of  the  paper,  and  not  its 
level  of  interest.  Authors  may,  as  before,  choose  to 
enquire  in  advance  of  submission  whether  their  paper 
will  seem  as  interesting  to  the  journal’s  advisors  and 
editors as it does to them.
A  more  unconventional  contribution  to  the  editorial 
policy of the fused journal will be the transfer intact from 
Journal of Biology of its re­review opt­out experiment [4]. 
This was conceived to address a widespread disgruntle­
ment  with  current  behavioral  tendencies  of  referees, 
memorably compared in a Comment article by Virginia 
Walbot in Journal of Biology [5] to those of pit bulls; and 
to  restore  a  greater  share  of  the  responsibility  for  the 
quality  of  the  published  paper  to  its  authors.  The 
rationale  for  and  operation  of  re­review  opt­out  are 
explained  in  the  editorial  [4]  we  published  when  we 
started the experiment, and I will not recapitulate them 
in detail here. But the essential point is that when authors 
revise a paper in response to referees (this applies only to 
revi  sions,  not  to  resubmissions),  they  may  choose 
whether  the  referees  are  consulted  again  before 
publication. We said we would continue the experiment 
for as long as it was having no clearly adverse effect on 
our ability to maintain the quality of published papers. 
This has not happened to date, and we will report back 
when  that  changes,  or  after  six  months  of  experience 
with the fusion journal, whichever is the sooner.
Hairballs revisited, the hope of progress, and the 
diversity of Q&As
For  the  inauguration  of  the  Journal  of  Biology-BMC 
Biology fusion, we are launching a new series – ‘The hope 
of progress’ – on biology relevant to clinical problems. I 
have  already  mentioned  our  Video  Q&A  with  Martin 
Raff, which is a special contribution to the series: the two 
other Hope of progress launch features are reviews on 
biology­based  cancer  therapy  [6]  and  on  vaccine 
adjuvants [7], and they are introduced in an accompany­
ing editorial [8], in which some of the issues of psychiatric 
genomics raised by Martin Raff are briefly discussed.
Our  other  Q&A  –  non­video  –  is  also  relevant  to 
psychiatric  genomics,  but  in  the  broader  context  of 
genome­wide association studies (GWAS) in general. In it, 
John Brookfield explains [9] the genetic and evolu  tionary 
principles  underlying  the  current  major  colla  bora  tive 
efforts  to  understand  what  has  become  known  as  the 
genetic architecture of complex diseases, how they can be 
bedevilled by the structure of populations, and why they 
may be most successful for the diseases of old age.
Brookfield’s Q&A joins earlier Journal of Biology Q&As 
tackling  concepts  critical  to  topical  issues  in  modern 
biology but with which modern biologists are not always 
wholly  at  ease  (see  [10]  for  a  full  listing  of  Journal  of 
Biology Q&As).
The very first of our Q&As was from James Ferrell [10], 
a lively assault on the confusion of the uninitiated about 
systems  biology,  and  featuring  the  familiar  systems 
biology hairball (see Figure 1 in [11]) – a representation 
of nodes and edges with more iconic than explanatory 
power. In this inaugural collection for the fusion journal, 
the hairball is revisited (and indeed the same hairball is 
reproduced)  in  an  article  by  Arthur  Lander  [12],  the 
author of one of our most accessed items of 2009 (on the 
stem cell concept [13]). Ferrell asked “What is systems 
biology?”  Lander  can  be  said  to  ask  rather  “Why  is 
systems biology?” – a question that he answers with an 
eloquent  and  absorbing  disquisition  on  the  absolute 
necessity of modelling, at all levels, if we wish to advance 
beyond knowledge to understanding.
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